Regeneron Pharma (REGN) PT Raised to $868 at Morgan Stanley
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $805.93 +0.30%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Morgan Stanley analyst Matthew Harrison raised the price target on Regeneron Pharma (NASDAQ: REGN) to $868.00 (from $851.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Regeneron Pharma (REGN) PT Raised to $756 at Bernstein SocGen Group
- JD Health International Inc (6618:HK) PT Lowered to HK$60 at Nomura/Instinet
- E Ink Holdings Inc (8069:TT) PT Lowered to NT$200 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
